CN114158725A - Preparation method of ginseng zymolyte containing polypeptide polysaccharide - Google Patents
Preparation method of ginseng zymolyte containing polypeptide polysaccharide Download PDFInfo
- Publication number
- CN114158725A CN114158725A CN202010950947.4A CN202010950947A CN114158725A CN 114158725 A CN114158725 A CN 114158725A CN 202010950947 A CN202010950947 A CN 202010950947A CN 114158725 A CN114158725 A CN 114158725A
- Authority
- CN
- China
- Prior art keywords
- ginseng
- weight
- parts
- zymolyte
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 101
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 100
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 96
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 150000004676 glycans Chemical class 0.000 title abstract description 9
- 229920001184 polypeptide Polymers 0.000 title abstract description 9
- 229920001282 polysaccharide Polymers 0.000 title abstract description 9
- 239000005017 polysaccharide Substances 0.000 title abstract description 9
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract description 9
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract description 9
- 241000208340 Araliaceae Species 0.000 title abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 29
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 14
- 108090000145 Bacillolysin Proteins 0.000 claims abstract description 13
- 108091005507 Neutral proteases Proteins 0.000 claims abstract description 13
- 102000035092 Neutral proteases Human genes 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 108010089934 carbohydrase Proteins 0.000 claims abstract description 5
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 3
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims description 97
- 239000000843 powder Substances 0.000 claims description 15
- 108010065511 Amylases Proteins 0.000 claims description 11
- 102000013142 Amylases Human genes 0.000 claims description 11
- 235000019418 amylase Nutrition 0.000 claims description 11
- 241000251468 Actinopterygii Species 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 10
- 108010035532 Collagen Proteins 0.000 claims description 10
- 229920001436 collagen Polymers 0.000 claims description 10
- 239000004382 Amylase Substances 0.000 claims description 9
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 235000002789 Panax ginseng Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 238000005728 strengthening Methods 0.000 claims description 6
- 240000005373 Panax quinquefolius Species 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 210000003734 kidney Anatomy 0.000 claims description 5
- 240000004371 Panax ginseng Species 0.000 claims description 4
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 4
- 241000276707 Tilapia Species 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 3
- 241000208343 Panax Species 0.000 claims description 3
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 3
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims description 3
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims description 3
- 229960002591 hydroxyproline Drugs 0.000 claims description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 3
- 108010084185 Cellulases Proteins 0.000 claims description 2
- 102000005575 Cellulases Human genes 0.000 claims description 2
- 241000180649 Panax notoginseng Species 0.000 claims description 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 2
- 241000168719 Panax zingiberensis Species 0.000 claims description 2
- 235000003176 Panax zingiberensis Nutrition 0.000 claims description 2
- 229940025131 amylases Drugs 0.000 claims description 2
- 238000012545 processing Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 230000036449 good health Effects 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 description 11
- 150000007949 saponins Chemical class 0.000 description 11
- 235000017709 saponins Nutrition 0.000 description 11
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229930182494 ginsenoside Natural products 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 229940089161 ginsenoside Drugs 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000000413 hydrolysate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000002929 anti-fatigue Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940107131 ginseng root Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- -1 etc. Natural products 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- FLZWAAFMRTZQGV-ULZIYQADSA-N n-[(2r,3r,4r,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2r,3s,4s,5r)-4,5,6-trihydroxy-1-oxo-2-[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxyoxan-3-yl]acetamide Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H](C=O)[C@H]([C@@H](O)[C@H](O)CO)O[C@@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 FLZWAAFMRTZQGV-ULZIYQADSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a preparation method of ginseng zymolyte containing polypeptide polysaccharide, belonging to the field of deep processing of traditional Chinese medicinal materials. The method of the invention comprises the following steps: pulverizing 100 weight parts of dried Ginseng radix, adding 500-2000 weight parts of water, adding 1-8 weight parts of carbohydrase at 30-65 deg.C, and reacting for 0.5-12 hr; 2) simultaneously adding 0.1-8 parts by weight of alkaline protease and 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours at the same temperature, or adding 0.1-8 parts by weight of alkaline protease to react for 0.5-12 hours, and then adding 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours; step 2) maintaining the pH value to be 6-9; 3) terminating the enzyme reaction of step 2). The method of the invention can improve the yield of effective components in the ginseng zymolyte, and the zymolyte has good health care and medicinal values.
Description
Technical Field
The invention belongs to the field of deep processing of traditional Chinese medicinal materials, and particularly relates to an enzymolysis process of ginseng.
Background
Ginseng (Panax ginseng) is the dried root of Panax ginseng C.A.Meyer of Araliaceae family, commonly known as herba Caesalpiniae, herba Bidentis Bipinnatae, herba Gei Piloselloidis, and radix Ginseng Indici.
The medicinal history of ginseng is long, and ginseng is listed as the top grade in Shen nong Ben Cao Jing, and is well known as Bai Cao Yao Wang. The research on the chemical composition of ginseng has been conducted for hundreds of years. Ginseng contains many components such as ginsenoside, polysaccharide, polypeptide, fatty acid, amino acid, volatile oil, flavone, vitamin, trace elements, etc., and ginsenoside is considered as one of its main active components. At present, ginseng is reported to contain more than 40 ginsenosides, and ginsenosides can be classified into three types according to the difference of aglycone structures: panaxadiol type, panaxatriol type and oleanolic acid type M. The composition of ginsenoside varies to different extent during processing, such as ginsenoside Rh2 and ginsenoside Rg3 which are not contained in Ginseng radix during processing into Ginseng radix Rubri. The determination result of amino acids in ginseng by using Weiyongdi and the like shows that the ginseng contains more than 17 amino acids, and the highest content of arginine. Monosaccharides found in ginseng include fructose, glucose, arabinose, etc., disaccharides include sucrose, maltose, etc., trisaccharides include raffinose, ginseng trisaccharide A, B, C, D, etc., and ginseng polysaccharides.
The application of the modern ginseng is mainly to accept western medicine theory and extract the saponin in the ginseng by extracting and purifying the ginsenoside by selecting an organic solvent or under the action of acid. For example, in the 'method for extracting ginsenoside and its application' disclosed in the patent application No. 201811610107.2, ginseng root is dried in an oven, crushed, extracted under microwave conditions with organic alcohol as a solvent, then adsorbed by macroporous resin, eluted with deionized water and ethanol, concentrated under reduced pressure, and dried to obtain total ginsenoside.
In addition, there is a method for extracting ginseng juice by treating ginseng using an enzyme engineering technique, such as "an enzymatic preparation method of full-ingredient ginseng juice" disclosed in patent application No. 201310355915.X, which is a method for extracting ginseng juice by hydrolyzing ginseng using complex enzyme. The operation is that the ginseng and water are pulped; finely grinding the ginseng pulp by using a colloid mill and adjusting the pH value to 2.5-4.5. And (3) steaming the ginseng pulp by using high-pressure steaming equipment at the steaming temperature of 102-115 ℃, putting the steamed ginseng into an enzymolysis tank, and carrying out enzymolysis twice under an acidic condition to obtain ginseng whole-component hydrolysate.
In addition, "enzymatic hydrolysis of ginseng and its activity study, the study of the Neugua, Jilin university of agriculture, the master academic paper of 2013" discusses the use of cellulase and amylase for enzymatic hydrolysis of ginseng. The cellulase is used for cracking cells and improving the dissolution of ginsenoside; the amylase is used for generating reducing sugar, provides raw materials for Maillard reaction, and increases the content of arginine monoglycoside and arginine diglycoside in the enzymatic hydrolysate.
However, the products obtained by the prior art lose a lot of active ingredients and cannot fully exert the medicinal function of the ginseng.
Disclosure of Invention
The invention aims to provide a preparation method of ginseng zymolyte containing polypeptide polysaccharide.
The technical scheme of the invention is as follows:
a ginseng enzymolysis method comprises the following steps:
1) pulverizing 100 weight parts of dry root of Panax plant, adding 500-2000 weight parts of water, adding 1-8 weight parts of carbohydrase at 30-65 deg.C, and reacting for 0.5-12 hr;
2) simultaneously adding 0.1-8 parts by weight of alkaline protease and 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours at the same temperature, or adding 0.1-8 parts by weight of alkaline protease to react for 0.5-12 hours, and then adding 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours;
3) terminating the enzyme reaction of step 2);
step 2) maintaining the pH value of 6-9.
According to the ginseng enzymolysis method, the ginseng plants in the step 1) are: ginseng (Panax ginseng), american ginseng (Panax quinquefolius), pseudoginseng (Panax pseudoginseng), or Panax notoginseng (Panax zingiberensis);
and/or the reaction time of step 1) is 3 hours;
and/or, the carbohydrases of step 1) are amylases and cellulases; preferably, the amylase in step 1) is used in an amount of 1-2 parts by weight, and the cellulase is used in an amount of 0.5-2 parts by weight.
The ginseng enzymolysis method is as described above, and the pH value of the step 2) is 8.
The ginseng enzymolysis method is characterized in that the alkaline protease in the step 2) accounts for 0.5-3 parts by weight; and/or the reaction time is 2-4 h.
According to the ginseng enzymolysis method, the neutral protease in the step 3) is 0.2-0.5 weight part; and/or the reaction time is 2 h.
According to the ginseng enzymolysis method, the step 3) is followed by the following steps:
4) filtering to obtain supernatant, concentrating under reduced pressure, and freeze drying to obtain dry powder.
A ginseng zymolyte is prepared by the method.
The ginseng zymolyte is prepared from the ginseng zymolyte, and the number average molecular weight of the ginseng zymolyte is 346;
and/or a number average molecular weight of 274;
and/or, Z average molecular weight is 515;
and/or, Z +1 has an average molecular weight of 878.
The ginseng zymolyte is used for preparing anti-fatigue or kidney-tonifying and yang-strengthening nutritional food, health-care products or medicines.
The nutritional food, the health product or the medicament also contains fish scale collagen;
preferably, the fish scale collagen is prepared by taking tilapia scales as raw materials, wherein the weight percentage of hydroxylysine is more than 1.3%; the weight average molecular weight is 800-2400; the hydroxyproline accounts for more than 7.3 percent by weight;
preferably, the weight ratio of the ginseng zymolyte to the fish scale collagen is 1: 9.
The invention has the following beneficial effects:
1) the product yield is high. Filtering the zymolyte (taking supernatant), and freeze-drying to obtain zymolyte dry powder with the content of the ginseng raw material being more than 40%.
2) The zymolyte has rich active substances. The polysaccharide, flavone, total nitrogen, protein and total saponin have high proportion in lyophilized powder.
3) Has high health and medicinal value. The zymolyte of the invention has good functions of resisting fatigue, tonifying kidney and strengthening yang.
Obviously, many modifications, substitutions, and variations are possible in light of the above teachings of the invention, without departing from the basic technical spirit of the invention, as defined by the following claims.
The foregoing aspects of the present invention are explained in further detail below with reference to specific embodiments. This should not be understood as limiting the scope of the above-described subject matter of the present invention to the following examples. All the technologies realized based on the above contents of the present invention belong to the scope of the present invention.
Drawings
FIG. 1: HPLC peak chart for saponin detection of comparative example 1.
FIG. 2: HPLC peak pattern for saponin detection of example 1.
FIG. 3: HPLC peak pattern (220nm wavelength) of the substrate of example 1.
Detailed Description
Example 1 preparation of ginseng zymolyte of the present invention
Crushing 100 g of ginseng sun-dried ginseng to 60-80 meshes, adding 1000 ml of water, keeping the temperature at 30-65 ℃, adding 2 g of cellulase and 1 g of amylase, and reacting for 3 hours; then, under the same temperature, keeping the pH value constant to 8, adding 0.5 g of alkaline protease to react for 2 hours under constant-temperature stirring, and then adding 0.5 g of neutral protease to react for 2 hours; then heating to 90 deg.C, reacting at constant temperature for half an hour to inactivate enzyme, and filtering. And concentrating the supernatant under reduced pressure at the vacuum degree of 0.06-0.10 Mpa and the temperature of 40-65 ℃, and freeze-drying to obtain solid ginseng zymolyte dry powder. The yield (weight of ginseng zymolyte dry powder/initial weight of ginseng zymolyte feed, the same below) is 51.2%.
Example 2 preparation of ginseng zymolyte of the present invention
Crushing 100 g of ginseng root hair to 60-80 meshes, adding 1000 ml of water, keeping the temperature at 30-65 ℃, adding 0.5 g of cellulase and 1 g of amylase, and reacting for 3 hours; then, under the same temperature, the pH value is kept constant to 8, 0.5 g of alkaline protease is added under constant temperature stirring for reaction for 2 hours, and then 0.5 g of neutral protease is added for reaction for 2 hours; then heating to 90 deg.C, reacting at constant temperature for half an hour to inactivate enzyme, and filtering. And concentrating the supernatant under reduced pressure at the vacuum degree of 0.06-0.10 Mpa and the temperature of 40-65 ℃, and freeze-drying to obtain solid ginseng zymolyte dry powder. The yield thereof was found to be 42.8%.
Example 3 preparation of ginseng zymolyte of the present invention
Crushing 100 g of American ginseng to 60-80 meshes, adding 1000 ml of water, keeping the temperature at 30-65 ℃, adding 1 g of cellulase and 2 g of amylase, and reacting for 3 hours; then, under the same temperature, the pH value is kept constant to 8, and 0.5 g of alkaline protease and 0.2 g of neutral protease are added to react for 2 hours under constant temperature stirring; then heating to 90 deg.C, reacting at constant temperature for half an hour to inactivate enzyme, and filtering. And concentrating the supernatant under reduced pressure at the vacuum degree of 0.06-0.10 Mpa and the temperature of 40-65 ℃, and freeze-drying to obtain solid ginseng zymolyte dry powder. The yield thereof was found to be 53.6%.
Example 4 Industrial production of ginseng zymolyte of the present invention
Crushing 100 kg of ginseng to be dried in the sun to 60-80 meshes, adding 1000 kg of water, keeping the temperature at 30-65 ℃, adding 1 kg of cellulase and 2 kg of amylase, and reacting for 3 hours; then, under the same temperature, 2N sodium hydroxide is used for adjusting the pH value to be 8, 500 g of alkaline protease and 200 g of neutral protease are added under constant temperature stirring for reaction for 2 hours; then heating to 90 deg.C, reacting at constant temperature for half an hour to inactivate enzyme, and filtering. Concentrating the supernatant under reduced pressure at 40-65 deg.C under 0.06-0.10 Mpa, and spray drying (inlet temperature 190 deg.C and outlet temperature 95 deg.C) to obtain solid Ginseng radix zymolyte dry powder with yield of 55%.
Comparative example 1 preparation of ginseng zymolyte
The alkaline protease was replaced with the acidic protease in the same manner as in example 1, and the pH was adjusted to 4, and the obtained enzymatic hydrolysate was filtered. And concentrating the supernatant under reduced pressure at the vacuum degree of 0.06-0.10 Mpa and the temperature of 40-65 ℃, and freeze-drying to obtain solid ginseng zymolyte dry powder. To obtain solid ginseng zymolyte dry powder. The yield thereof was found to be 23.6%.
Comparative example 2 preparation of ginseng zymolyte
Crushing 100 g of ginseng sun-dried ginseng to 60-80 meshes, adding 1000 ml of water, keeping the temperature at 30-65 ℃, adding 2 g of cellulase and 1 g of amylase, and reacting for 3 hours; then, under the same temperature, the pH value is kept constant to 3, and 0.5 g of acid protease is added under constant temperature stirring for reaction for 3 hours; then heating to 90 deg.C, reacting at constant temperature for half an hour to inactivate enzyme, and filtering. And concentrating the supernatant under reduced pressure at the vacuum degree of 0.06-0.10 Mpa and the temperature of 40-65 ℃, and freeze-drying to obtain solid ginseng zymolyte dry powder. The yield thereof was found to be 31.5%.
The advantageous effects of the present invention are further described below by way of test examples.
Test example 1 characterization of the composition of matter of the dry powder of the enzymatic hydrolysate
The contents of polysaccharide, flavone, total nitrogen, protein and total saponin in the zymolyte dry powder of the previous examples were measured, and the results are shown in table 1.
TABLE 1 content of major components of the enzymatic hydrolysate (in weight percent)
Polysaccharides | Flavone | Total nitrogen | Protein content | Total saponin content | |
Example 1 | 54.14% | 0.80% | 2.45% | 15.31% | 10.18% |
Example 2 | 76.86% | 1.04% | 2.49% | 15.57% | 6.75% |
Example 3 | 57.16% | 0.87% | 2.34% | 14.63% | 5.85% |
Comparative example 1 | 68.16% | 0.80% | 1.97% | 12.33% | 5.28% |
Comparative example 2 | 16.53% | 0.97% | 1.57% | 9.82% | 3.86% |
Wherein, the HPLC peak diagrams of the saponin detection of comparative example 1 and example 1 are shown in FIG. 1 and FIG. 2, respectively, and the corresponding statistics of various saponins are shown in Table 2 and Table 3, respectively.
TABLE 2 comparative example 1 saponin substance HPLC detection values
TABLE 3 HPLC-DETECTION PEAK PATTERN OF SAPONIN IN DRY POWDER OF THE zymolyte obtained in example 1
From the comparison results, the method of the invention uses a specific enzymolysis process, which not only can improve the yield of the zymolyte, but also can improve the content of the saponin in the zymolyte.
Test example 2 molecular weight characterization of ginseng zymolyte of example 1
The number average molecular weight, weight average molecular weight, Z average molecular weight, and Z +1 average molecular weight of the ginseng zymolyte in example 1 were measured. The detection spectrum is shown in FIG. 3. The relative molecular weight results are shown in table 4.
Table 4 example 1 zymolyte molecular weight characterization
Experimental example 3 application experiment of ginseng zymolyte in anti-fatigue population
The crowd data: selection of 10 subjects, age: the age of the male is 30-55 years, and the male and the female are 5 cases respectively. The testees are easy to fatigue, sleepiness is achieved within 1 hour of driving, afternoon nap is needed, otherwise, the work cannot concentrate on the work.
The subject takes the sun-dried ginseng powder continuously for 10 days; after 20 days, the zymolyte of example 4 is taken for 10 consecutive days; after another 20 days, the enzymatic hydrolysate of comparative example 1 was administered for 10 consecutive days.
The taking method comprises the following steps: the preparation is taken orally once a day, 1 g each time, dissolved in warm water. It is administered in the morning on an empty stomach.
As shown in Table 5, the fatigue-preventing effect of example 4 was the best.
TABLE 5 anti-fatigue test of ginseng zymolyte
And (4) conclusion: the ginseng zymolyte has good anti-fatigue effect, and the effect is better than that of the untreated ginseng powder and ginseng zymolyte produced by other processes.
Test example 4 application experiment of ginseng zymolyte in invigorating kidney and strengthening yang
1. Method of producing a composite material
(1) Experimental group
In total 8 cases, 45-65 years old, male, no morning bobble had been for about 1 year.
The ginseng zymolyte and the fish scale collagen polypeptide are compounded at a ratio of 1: 9(w/w), 10 g of the compound is taken once a day on an empty stomach. After taking for 15 days, the effect is observed.
The ginseng zymolyte is prepared by the process of example 4.
(2) Control group
In total 4 cases, 55-60 years old, male, no morning bobble had been for about 1 year.
The ginseng zymolyte and the fish scale collagen polypeptide are compounded at a ratio of 1: 9(w/w), 10 g of the compound is taken once a day on an empty stomach. After taking for 15 days, the effect is observed.
The ginseng zymolyte is prepared by the process of comparative example 1.
The fish scale collagen polypeptide of the experimental group and the control group is prepared by taking tilapia scales as raw materials, wherein the weight percentage of hydroxylysine is more than 1.3%; the weight average molecular weight is 800-2400; the hydroxyproline accounts for more than 7.3 percent by weight;
the fish scale collagen polypeptide can be prepared according to the method disclosed by the patent publication No. CN104223115B, and specifically comprises the following steps:
a. taking 100 parts by weight of tilapia scales as a raw material, adding 800-1200 parts by weight of water, heating to 80-90 ℃, and keeping the temperature for 20-60 minutes;
b. then cooling to 30-65 ℃, adjusting the pH value to 8-9, adding 1-8 parts of alkaline protease, and degrading for 0.5-12 hours at constant temperature;
c. adding 1-8 parts of neutral protease at the constant temperature of 45-50 ℃, and stirring for reaction for 0.5-12 hours;
d. then heating to 75-90 ℃, and preserving the heat for 15-30 minutes to inactivate the enzyme;
e. adding flocculant, flocculating to precipitate impurities, filtering, and spray drying the filtrate.
2. Results
In the experimental group: morning bobs appear on the second day after 1 case is taken, morning bobs appear on the second day after 2 cases are taken for one week, and morning bobs appear on the second day after 5 cases are taken for 10 days.
In the control group: after one week, morning puffs appeared in 1 person, and in other 3 cases, mental condition was improved, but no morning puffs appeared.
3. Conclusion
The zymolyte of the invention has good effects of invigorating the kidney and strengthening yang.
In conclusion, the product prepared by the preparation process of the ginseng zymolyte has high yield, rich enzymolysis active substances, good effects of resisting fatigue, tonifying kidney and strengthening yang, and good application prospect.
Claims (10)
1. A ginseng enzymolysis method is characterized by comprising the following steps:
1) pulverizing 100 weight parts of dry root of Panax plant, adding 500-2000 weight parts of water, adding 1-8 weight parts of carbohydrase at 30-65 deg.C, and reacting for 0.5-12 hr;
2) simultaneously adding 0.1-8 parts by weight of alkaline protease and 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours at the same temperature, or adding 0.1-8 parts by weight of alkaline protease to react for 0.5-12 hours, and then adding 0.1-8 parts by weight of neutral protease to react for 0.5-12 hours;
3) terminating the enzyme reaction of step 2);
step 2) maintaining the pH value of 6-9.
2. The ginseng enzymatic hydrolysis method according to claim 1, wherein: the Panax plants in the step 1) are as follows: ginseng (Panax ginseng), american ginseng (Panax quinquefolius), pseudoginseng (Panax pseudoginseng), or Panax notoginseng (Panax zingiberensis);
and/or the reaction time of step 1) is 3 hours;
and/or, the carbohydrases of step 1) are amylases and cellulases; preferably, the amylase in step 1) is used in an amount of 1-2 parts by weight, and the cellulase is used in an amount of 0.5-2 parts by weight.
3. The ginseng enzymatic hydrolysis method according to claim 1 or 2, wherein: the pH value in step 2) is 8.
4. The ginseng enzymatic hydrolysis method according to claim 1 or 2, wherein: 0.5-3 parts by weight of alkaline protease in the step 2); and/or the reaction time is 2-4 h.
5. The ginseng enzymatic hydrolysis method according to claim 1 or 2, wherein: 0.2 to 0.5 weight portion of neutral protease in the step 3); and/or the reaction time is 2 h.
6. The ginseng enzymatic hydrolysis method according to claim 1 or 2, wherein: the step 3) is followed by the following steps:
4) filtering to obtain supernatant, concentrating under reduced pressure, and freeze drying to obtain dry powder.
7. A ginseng zymolyte is characterized in that: the zymolyte is prepared by the method of any one of claims 1 to 8.
8. The ginseng zymolyte of claim 7, wherein: the number average molecular weight of the ginseng zymolyte is 346;
and/or a number average molecular weight of 274;
and/or, Z average molecular weight is 515;
and/or, Z +1 has an average molecular weight of 878.
9. Use of the ginseng zymolyte of claim 7 or 8 in preparing a nutritional food, a health product or a medicament for resisting fatigue, tonifying kidney and strengthening yang.
10. Use according to claim 9, characterized in that: the nutritional food, the health product or the medicine also contains fish scale collagen;
preferably, the fish scale collagen is prepared by taking tilapia scales as raw materials, wherein the weight percentage of hydroxylysine is more than 1.3%; the weight average molecular weight is 800-2400; the hydroxyproline accounts for more than 7.3 percent by weight;
preferably, the weight ratio of the ginseng zymolyte to the fish scale collagen is 1: 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010950947.4A CN114158725A (en) | 2020-09-10 | 2020-09-10 | Preparation method of ginseng zymolyte containing polypeptide polysaccharide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010950947.4A CN114158725A (en) | 2020-09-10 | 2020-09-10 | Preparation method of ginseng zymolyte containing polypeptide polysaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114158725A true CN114158725A (en) | 2022-03-11 |
Family
ID=80475854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010950947.4A Pending CN114158725A (en) | 2020-09-10 | 2020-09-10 | Preparation method of ginseng zymolyte containing polypeptide polysaccharide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114158725A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101289507A (en) * | 2007-04-17 | 2008-10-22 | 史宗洁 | Collagen protein and collagen polypeptides, preparation thereof and applications |
CN108486202A (en) * | 2018-05-25 | 2018-09-04 | 成都金希生态农业开发股份有限公司 | A kind of Moringa zymolyte and its preparation method and application |
CN109457008A (en) * | 2018-12-28 | 2019-03-12 | 河北肽都生物科技有限公司 | A kind of preparation method of ginseng chelating peptide |
CN109517870A (en) * | 2019-01-24 | 2019-03-26 | 吉林大学 | A kind of method of double enzyme stepwise discretization preparation ginseng polypeptides |
CN110881629A (en) * | 2018-09-10 | 2020-03-17 | 成都利涛恒福生物科技有限公司 | Red date zymolyte and preparation method and application thereof |
-
2020
- 2020-09-10 CN CN202010950947.4A patent/CN114158725A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101289507A (en) * | 2007-04-17 | 2008-10-22 | 史宗洁 | Collagen protein and collagen polypeptides, preparation thereof and applications |
CN108486202A (en) * | 2018-05-25 | 2018-09-04 | 成都金希生态农业开发股份有限公司 | A kind of Moringa zymolyte and its preparation method and application |
CN110881629A (en) * | 2018-09-10 | 2020-03-17 | 成都利涛恒福生物科技有限公司 | Red date zymolyte and preparation method and application thereof |
CN109457008A (en) * | 2018-12-28 | 2019-03-12 | 河北肽都生物科技有限公司 | A kind of preparation method of ginseng chelating peptide |
CN109517870A (en) * | 2019-01-24 | 2019-03-26 | 吉林大学 | A kind of method of double enzyme stepwise discretization preparation ginseng polypeptides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719880B (en) | Preparation method of high-activity purple sweet potato dietary fiber | |
EP2778177A1 (en) | Method for extracting polysaccharides from higher plants and fungi through microwave chemical treatment | |
CN101402627B (en) | Synchronous separation, extraction and purification method for flavone, alkaloid and polysaccharide in lotus leaf | |
KR101487542B1 (en) | An manufacturing method of ginseng polysaccharide for immunopotentiating and compositions comprising thereof | |
KR101328413B1 (en) | An extracting method of ginseng by high pressure/enzyme decomposition | |
CN102304501A (en) | Complex enzyme preparation and application and method thereof for extracting plant polysaccharides by using same | |
CN112401239A (en) | Composition for reducing blood sugar and preparation method and application thereof | |
CN1510143A (en) | Extraction of milk vetch polysaccharide by enzyme treatment | |
CN115531430B (en) | Ginseng extract or ginseng extract, preparation method and application thereof | |
CN109897119B (en) | Lycium barbarum polysaccharide, method for controlling pH value and concentrating during preparation of lycium barbarum polysaccharide and application of lycium barbarum polysaccharide | |
CN114158725A (en) | Preparation method of ginseng zymolyte containing polypeptide polysaccharide | |
CN114107418B (en) | Preparation method of ginseng polypeptide | |
CN108126000B (en) | Method for extracting and preparing panax notoginseng saponins from fresh panax notoginseng | |
CN114560959A (en) | Preparation method of mushroom extract | |
CN114098089A (en) | Composite peptide composition and composite peptide seasoning tea | |
CN113425754A (en) | Method for combined extraction of flavone and pectin from passion fruit peel | |
KR101877225B1 (en) | Method for Manufacturing Tablet Containing Fermented Ginseng and Maca | |
CN106884026B (en) | Active polysaccharide rich in flavonoid compounds and preparation method thereof | |
KR20200132439A (en) | Method for Manufacturing Fermented Ginseng Tablet | |
KR20080044942A (en) | Ginseng preparations containing a high concentration of ginseng sapogenin using a bacillus natto and method thereof | |
CN116370367B (en) | Plant extract for cosmetics and preparation method and application thereof | |
CN117679448B (en) | Method for extracting and purifying total saponins of panax notoginseng | |
CN111000881B (en) | Propolis soft capsule rich in flavone and belonging to genus Brazilian breynia and preparation method thereof | |
CN112891385B (en) | Cooked pseudo-ginseng and preparation method thereof | |
KR20200000571A (en) | Method for preparing fermentation products of Panax ginsengberry improved contents of low molecular gingenosides and cosmetic compositions comprising fermentation products of Panax ginsengberry prepared thereby |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |